P-63 Efficacy, Safety and Prognostic Subgroups for Outcome with Regorafenib in Patients with Refractory Metastatic Colorectal Cancer in the Real-World Setting: the CORE Study
Annals of oncology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of oncology(2022)